Cargando…

Evaluating the utility of a two‐assay serological algorithm for hepatitis C screening in a low prevalence population

INTRODUCTION: Screening for hepatitis C virus (HCV) is performed by testing for anti‐HCV antibodies, which may yield false‐positive results leading to additional testing and other downstream consequences for the patient. We report our experience in a low prevalence population (<0.05%) using a two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogers, Kai J., Halvorson, Tracy S., Krasowski, Matthew D., Merrill, Anna E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220299/ https://www.ncbi.nlm.nih.gov/pubmed/37106580 http://dx.doi.org/10.1002/jcla.24887

Ejemplares similares

The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations
por: Huang, Yanfang, et al.
Publicado: (2021)

Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease
por: Khan, Farhan, et al.
Publicado: (2022)

Comparison of a qualitative immunochromatographic test with two quantitative serological assays for the detection of antibodies to Leishmania infantum in dogs
por: Villanueva-Saz, Sergio, et al.
Publicado: (2019)

Serology in COVID-19: Comparison of Two Methods †
por: Moniuszko-Malinowska, Anna, et al.
Publicado: (2021)

Data on the relationship of signal-to-cutoff ratio of two HIV antigen/antibody combination assays to subsequent confirmation of HIV-1 infection in a low-prevalence population
por: Hodgson, Christina K., et al.
Publicado: (2020)

Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: Hashem, Anwar M., et al.
Publicado: (2020)

Low Risk of Serological Cross-Reactivity between the Dengue Virus and SARS-CoV-2-IgG Antibodies Using Advanced Detection Assays
por: Shurrab, Farah M., et al.
Publicado: (2022)

Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms
por: Turbett, Sarah E., et al.
Publicado: (2020)

Serological Survey of Lyssaviruses in Polish Bats in the Frame of Passive Rabies Surveillance Using an Enzyme-Linked Immunosorbent Assay
por: Orłowska, Anna, et al.
Publicado: (2020)

Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients
por: Vauloup-Fellous, Christelle, et al.
Publicado: (2021)

Utility of Polymerase Chain Reaction Versus Serology-Based Testing in Immunocompromised Patients With Bartonella henselae Infection
por: Kumar, Ankit, et al.
Publicado: (2023)

Practical Considerations for Implementation of SARS-CoV-2 Serological Testing in the Clinical Laboratory: Experience at an Academic Medical Center
por: Humble, Robert M., et al.
Publicado: (2021)

Utility of asymptomatic inpatient testing for COVID-19 in a low-prevalence setting: A multicenter point-prevalence study
por: Bai, Anthony D., et al.
Publicado: (2020)

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2023)

Low Yield of Hepatitis C Infection in an Outreach Screening Program in Harris County, Texas
por: Kim, Hyun-seok, et al.
Publicado: (2020)

Utility of serological screening for measles, mumps and rubella in immunocompromised patients
por: Sticchi, L, et al.
Publicado: (2019)

Evaluation of Two Serological Assays for Diagnosing Zika Virus Infection
por: Loyola, Steev, et al.
Publicado: (2021)

Evaluation of Chikungunya Diagnostic Assays: Differences in Sensitivity of Serology Assays in Two Independent Outbreaks
por: Yap, Grace, et al.
Publicado: (2010)

Product Choice Affects Risk of False-Positive Hepatitis B Virus Serology During Immunoglobulin Replacement Therapy
por: Lindahl, Hannes, et al.
Publicado: (2023)

Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays
por: Kweon, Oh Joo, et al.
Publicado: (2020)

Clinical Utility Validation of an Automated Ultrarapid Gene Fusion Assay for NSCLC
por: Buglioni, Alessia, et al.
Publicado: (2022)

Serological Assay and Genotyping of Hepatitis C Virus in Infected Patients in Zanjan Province
por: Esmaeilzadeh, Abdolreza, et al.
Publicado: (2014)

Epitope-Specific Serological Assays for RSV: Conformation Matters
por: Phung, Emily, et al.
Publicado: (2019)

The Prevalence and Serological Association of Hepatitis D Virus Genotypes in Taiwan
por: Joseph, Keva, et al.
Publicado: (2021)

Comparison of Two PCR Assays for Trichomonas vaginalis
por: Noh, Chang-Suk, et al.
Publicado: (2019)

Utilizing technology to enhance screening for highly infectious diseases
por: Ehni, Jordan, et al.
Publicado: (2021)

Prospective Observational COVID-19 Screening and Monitoring of Asymptomatic Cancer Center Health-Care Workers with a Rapid Serological Test
por: Paradiso, Angelo Virgilio, et al.
Publicado: (2021)

Agreement Between Two Procalcitonin Assays in Hospitalized Children
por: Katz, Sophie E., et al.
Publicado: (2019)

Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection
por: Cloherty, Gavin, et al.
Publicado: (2016)

Calibrating Hepatitis E Virus Serological Assays Using Asymptomatic Specimens Obtained in Japan
por: Terahara, Kazutaka, et al.
Publicado: (2022)

Universal screening for the SARS-CoV-2 virus on hospital admission in an area with low COVID-19 prevalence
por: Sastry, Sangeeta R., et al.
Publicado: (2020)

Systematic screening for novel, serologically reactive Hepatitis E Virus epitopes
por: Osterman, Andreas, et al.
Publicado: (2012)

SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing
por: Rathe, Jennifer A, et al.
Publicado: (2020)

The Performance of Nine Commercial Serological Screening Assays for the Diagnosis of Lyme Borreliosis: a Multicenter Modified Two-Gate Design Study
por: Hoeve-Bakker, B. J. A., et al.
Publicado: (2022)

Unexpected False-Positive Rates in Pediatric SARS-CoV-2 Serology Using the EUROIMMUN Anti-SARS-CoV-2 ELISA IgG Assay
por: Geisler, Daniel, et al.
Publicado: (2021)

Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
por: Ripperger, Tyler J., et al.
Publicado: (2020)

Immunofluorescence Assay for Serologic Diagnosis of SARS
por: Chan, Paul K. S., et al.
Publicado: (2004)

Understanding the patient population and test utilization for hepatitis B virus testing
por: Choi, Rihwa, et al.
Publicado: (2019)

Prevalence of Hepatitis B Virus and Hepatitis C Virus in a Tea Garden of Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2017)

The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
por: Karger, Amy B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ebpujlrjtqal9vgu3cd97m1lf